From the ODAC Poster Hall | Chronic Urticaria Exposure During Residency
Chronic urticaria is a common dermatologic condition, yet according to a recent survey, one in five clinicians deviates from known management guidelines. Researchers at the George Washington University (GWU) School of Medicine and Health Sciences Department of Dermatology surmised that the lack of confidence in workup and management of chronic urticaria and lack of adherence to guidelines may stem …
Chronic urticaria is a common dermatologic condition, yet according to a recent survey, one in five clinicians deviates from known management guidelines. Researchers at the George Washington University (GWU) School of Medicine and Health Sciences Department of Dermatology surmised that the lack of confidence in workup and management of chronic urticaria and lack of adherence to guidelines may stem … Continue reading "From the ODAC Poster Hall | Chronic Urticaria Exposure During Residency"
Hair loss visits are common but, if you’re like me, it can still give pause in a busy clinic. During a session titled Strands of Clarity: Mastering the Hair & Scalp Exam at the ODAC Dermatology conference, Dr. Ronda Farah— nationally and internationally recognized in hair loss and serving as an Associate Professor in the Department of Dermatology at the University of Minnesota—focused on … 
5-aminolevulinic acid (5-ALA) is an FDA-approved prodrug used in combination with light therapy for treatment of actinic keratosis and superficial basal cell carcinoma. It is a naturally occurring amino acid that is an intermediate of the heme biosynthesis pathway which cells convert into the photosensitizing metabolite protoporphyrin IX (PpIX). This compound has been applicable in two specific cl … 
The FDA’s approval of delgocitinib for chronic hand eczema is shining a light on this and other regional eczemas. Next Steps in Derm, in partnership with the ODAC Dermatology Conference, interviewed Peter A. Lio, MD, FAAD, clinical assistant professor of dermatology and pediatrics at the Northwestern University Feinberg School of Medicine. Watch as Dr. Lio shares the burden of chronic hand eczem … 
GLP-1s are ushering in a new era of medical treatment, and cosmetic dermatologists are feeling the impact. Patients who are experiencing weight loss from GLP-1s are seeking help with the cosmetic side effects, especially with the loss of facial volume. Next Steps in Derm, in partnership with the ODAC Dermatology Conference, interviewed Sarah Jackson, MD, FAAD, associate clinical professor of derma …